The World Bladder Cancer Patient Coalition (WBCPC) has co-signed the WECAN Foundation Open Letter, “Cancer Cannot Wait: Safeguard Health as a Standalone Priority in the EU Budget” joining patient organisations, healthcare professionals, researchers, and civil society groups across Europe in calling on Members of the European Parliament (MEPs) to protect health funding in the next EU Budget.
Below is the full Open Letter calling for immediate action.
We are pleased to announce that our bladder cancer treatment factsheets are now available in French, further expanding access to trusted, patient-friendly information for French-speaking individuals and communities worldwide.
These resources cover two key areas of bladder cancer:
Navigating a bladder cancer diagnosis and understanding treatment options can be challenging. These factsheets have been designed to present essential information in a clear and structured way,
Bladder Cancer Awareness Month (BCAM) 2026 is approaching and this year carries particular importance.
It marks the final year of the global “Feeling unsure? Get checked.” campaign, a three-year effort focused on one critical issue: people often hesitate to seek medical advice when they notice potential symptoms, especially blood in the urine.
This hesitation can delay diagnosis and affect outcomes. Yet early detection makes a real difference.
Every year on 7 April, World Health Day draws attention to key global health priorities. The 2026 theme, “Together for health. Stand with science” highlights the importance of research, evidence and collaboration in improving health outcomes for people around the world.
At the World Bladder Cancer Patient Coalition, this message reflects the work we do every day. Scientific progress has led to improvements in the diagnosis and treatment of bladder cancer,
The World Bladder Cancer Patient Coalition is pleased to share the publication of Mission Early’s Call to Action for Better Early Cancer Care, a global initiative calling for stronger policies to support early detection, diagnosis and treatment of cancer.
The Call to Action was initially launched in November 2025 during the Union for International Cancer Control (UICC) World Cancer Leaders’ Summit in Melbourne. It was later brought to the European policy stage during a roundtable discussion titled “Beating Cancer Early: From Evidence to Action”,
At the Cancer Drug Development Forum (CDDF) Workshop 2026, held on March 30, 2026, in Brussels, Belgium, our Executive Director, Alex Filicevas, spoke during the session “Challenges in the Landscape of a Global Development Strategy, including patient access”, focusing on the role of patient-reported outcomes (PROs) in cancer clinical trials.
PROs are used in clinical trials to capture how patients feel during and after treatment. They provide important insight into symptoms,
We are pleased to share that two of our bladder cancer factsheets on treatment are now available in Spanish, expanding access to reliable, patient-friendly information for Spanish-speaking communities worldwide.
These resources focus on:
Understanding bladder cancer and its treatment options can be complex. These factsheets have been developed to provide clear, structured information that helps patients and carers better understand their diagnosis,
Bladder Cancer Awareness Month 2026 (BCAM26) is approaching, and we are pleased to share this year’s campaign toolkit.
This May marks the final year of our global Feeling Unsure? Get Checked campaign. Over the past three years, this initiative has focused on one key message: when something feels unusual, especially blood in the urine, it is important to seek medical advice without delay. This final year builds on that momentum,